Clinical Trials Logo
  1. Home
  2. Bone Tumor
  3. NCT04798326

Comparing of the Pharmacokinetic, Pharmacodynamic, Safety and Immunogenicity of MW032 and Xgeva® in Healthy Adults — MW032  

Bone Tumor Clinical Trial

Official title:
A Single Center, Randomized, Double-blind , Single-dose, and Parallel Group Study to Compare the Pharmacokinetic, Safety and Pharmacodynamic of MW032 and Xgeva® in Healthy Adults

Clinical Trial Summary

A randomized, double-blind and parallel group study to compare the pharmacokinetic, safety and pharmacodynamic of MW032 and Xgeva® in healthy adults.

Clinical Trial Description

This is a phase I, single center, randomized, double-blind and parallel group clinical trial. The primary objective is to assess the pharmacokinetic similarity of single and subcutaneous injections of MW032 and Xgeva® in healthy volunteers. The secondary objective are to assess the Clinical safety and immunogenicity similarity of single and subcutaneous injections of MW032 and Xgeva® in healthy volunteers. At the same time, preliminary evaluate the pharmacodynamic similarity between MW032 and Xgeva®. Subjects would receive a single 120mg（1.7mL）of MW032 or Xgeva® through subcutaneous injection. ;

Study Design

Related Conditions & MeSH terms

Clinical Trial Details
NCT number NCT04798326
Study type Interventional
Source Mabwell (Shanghai) Bioscience Co., Ltd.
Contact
Status Completed
Phase Phase 1
Start date June 25, 2019
Completion date February 26, 2020
View Details
See also
  Status Clinical Trial Phase
Not yet recruiting NCT05515068 - Registry For Children, Adolescents And Adults With Osteosarcoma And Biologically Related Bone Sarcomas
Completed NCT02862288 - Preliminary Study of Microwave Tumoral Ablation Performances for the Treatment of Pulmonary, Renal and Bone Neoplasia. Phase 1/Phase 2
Withdrawn NCT01679691 - The Epidural Anesthesia on the Intra-operative and Post-operative Amount of Bleeding Post Lower Limb Salvage Surgery N/A
Recruiting NCT04178044 - Phase Ⅰ Clinical Study Protocol of GB223 Monoclonal Antibody Injection Phase 1
Completed NCT03389724 - Prevention of Chemotherapy Induced Cardiotoxicity in Children With Bone Tumors and Acute Myeloid Leukemia Phase 3
Completed NCT05075889 - Utility of ICG in Benign Bone Tumors Early Phase 1
Recruiting NCT04755140 - Endoprosthesis Metal Toxicity Study
Not yet recruiting NCT03427632 - Role of Percutaneous Vertebroplasty in Treatment of Vertebral Tumors N/A
Active, not recruiting NCT04104750 - The Assessment of Fatigue and Quality of Life in Patients With Bone Tumor,
Completed NCT00598741 - Dynamic Contrast Enhanced MRI(DCE-MRI)of Bone Tumors N/A
Completed NCT02398058 - Trabectedin Plus Olaparib in Metastatic or Advanced Sarcomas (TOMAS) Phase 1
Recruiting NCT06171282 - A Clinical Study on Oncolytic Virus Injection (R130) for the Treatment of Advanced Bone and Soft Tissue Tumors Early Phase 1
Not yet recruiting NCT06376682 - EPIBONE Study: a Prospective Study on Feasibility, Safety and Accuracy N/A
Enrolling by invitation NCT05772312 - Quality of Life of Patients With Bone Tumor of the Lower Limbs Treated With Salvage Surgery
Recruiting NCT05779670 - Adherence to a Personalized Home Exercise Program in Patients With Bone Tumor Undergoing Lower Extremity Salvage Surgery
Completed NCT05732558 - Augmented Reality Navigation System (Endosight) for the Guidance of Bone Biopsy N/A
Recruiting NCT06180525 - Radiological Evaluation of 3D Printed Porous Collars in Hip and Knee Resection Prostheses: Pilot Study.
Completed NCT04955522 - Multimodal Imaging Analysis of Spinal Tumors
Recruiting NCT05631002 - Chemical Shift Encoding-based Water-fat Magnetic Resonance Imaging in Spinal Tumors
Recruiting NCT06008483 - A Dose Finding Study to Treat Bone Tumor(s) Phase 1